Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

PhyNexus Announces the Launch of the Enhanced MEA 2 Personal Purification System

Published: Friday, November 08, 2013
Last Updated: Friday, November 08, 2013
Bookmark and Share
PhyNexus Inc. launches of its next generation platform for automated chromatography applications.

The MEA 2 is designed to process PhyTip® columns for automated and unattended purification and enrichment of soluble and membrane proteins and plasmid DNA.

PhyNexus.gifThe MEA 2 features a redesigned 12-channel head pipette system. This incorporates improved performance and reliability, even with viscous liquids and is suitable for cold room usage.

The back and forth active transport in the PhyTip chromatography column drives binding and elution to equilibrium maximising yield and concentration. The system is capable of processing samples sizes from 100 µL up to 80mL allowing great flexibility in a personal robotic platform. In addition to excellent purification, the ability to perform elutions in volumes as low as 10 µL provides excellent sample concentration.

Application areas that benefit from the features of the enhanced MEA 2 include process development, parallel large volume purification and crystallography sample preparation.

 “We are finding that the popularity of our MEA robotic systems is increasing rapidly” says PhyNexus CEO, Douglas Gjerde, Ph.D. “Historically, our MEA line has filled an important niche for our customers.  Unlike larger systems our robotic system sits on any bench top and is easy to program by our research customers who are actually using the system while still providing the automation and throughput that our customer need.  We are pleased with the early success of this new MEA 2 offering.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Head Injury Patients have Protein Clumps Associated with Alzheimer’s Disease
Scientists have revealed that protein clumps associated with Alzheimer's disease are also found in the brains of people who have had a head injury.
Exposure to Air Pollution 30 Years Ago Associated with Increased Risk of Death
Exposure to air pollution more than 30 years ago may still affect an individual's mortality risk today, according to new research from Imperial College London.
More Then 1 in 20 U.S. Children have Dizziness and Balance Problems
Researchers at NIH have found that girls have a higher prevalence of dizziness and balance problems compared to boys, 5.7 percent and 5.0 percent.
Biosensors on Demand
New strategy results in custom "designer proteins" for sensing a variety of molecules.
Low-Cost, Portable NQR Spectroscopy
A researcher at Case Western Reserve University is developing a low-cost, portable prototype designed to detect tainted medicines and food supplements that otherwise can make their way to consumers. The technology can authenticate good medicines and supplements.
Structure of Brain Plaques in Huntington's
Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder.
Insights into the Function of the Main Class of Drug Targets
About thirty percent of all medical drugs such as beta-blockers or antidepressants interact with certain types of cell surface proteins called G protein coupled receptors.
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Unique Mechanism for a High-Risk Leukemia
Researchers uncovered the aberrant mechanism underlying a notoriously treatment-resistant acute lymphoblastic leukemia subtype; findings offer lessons for understanding all cancers.
Visualizing a Cancer Drug Target at Atomic Resolution
Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!